Axsome Therapeutics Inc (NASDAQ: AXSM) kicked off on Tuesday, up 4.16% from the previous trading day, before settling in for the closing price of $116.31. Over the past 52 weeks, AXSM has traded in a range of $75.56-$139.13.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
A company in the Healthcare sector has dropped its sales by -24.44% annually for the last half of the decade. While this was happening, its average annual earnings per share was recorded 42.10%. With a float of $41.04 million, this company’s outstanding shares have now reached $49.82 million.
Axsome Therapeutics Inc (AXSM) Insider Updates
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Axsome Therapeutics Inc is 17.75%, while institutional ownership is 75.87%. The most recent insider transaction that took place on Aug 26 ’25, was worth 2,400,600. In this transaction Director of this company sold 20,000 shares at a rate of $120.03, taking the stock ownership to the 130,974 shares. Before that another transaction happened on Aug 22 ’25, when Company’s Director sold 16,694 for $120.08, making the entire transaction worth $2,004,616. This insider now owns 150,974 shares in total.
Axsome Therapeutics Inc (AXSM) Performance Highlights and Predictions
In the latest quarterly report, which was put into the public domain on 9/30/2024, the organization reported -1.34 earnings per share (EPS), higher than consensus estimate (set at -1.39) by 0.05. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.6 per share during the current fiscal year.
Axsome Therapeutics Inc (NASDAQ: AXSM) Trading Performance Indicators
Take a look at Axsome Therapeutics Inc’s (AXSM) current performance indicators. Last quarter, stock had a quick ratio of 1.51. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 12.21.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -5.07, a number that is poised to hit -0.83 in the next quarter and is forecasted to reach 1.13 in one year’s time.
Technical Analysis of Axsome Therapeutics Inc (AXSM)
Let’s dig in a bit further. During the last 5-days, its volume was 0.55 million. That was inferior than the volume of 0.77 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 86.73%.
During the past 100 days, Axsome Therapeutics Inc’s (AXSM) raw stochastic average was set at 98.99%, which indicates a significant increase from 98.22% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 3.34 in the past 14 days, which was lower than the 3.83 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $106.94, while its 200-day Moving Average is $106.47. However, in the short run, Axsome Therapeutics Inc’s stock first resistance to watch stands at $123.05. Second resistance stands at $124.95. The third major resistance level sits at $128.40. If the price goes on to break the first support level at $117.70, it is likely to go to the next support level at $114.25. Assuming the price breaks the second support level, the third support level stands at $112.35.
Axsome Therapeutics Inc (NASDAQ: AXSM) Key Stats
The company with the Market Capitalisation of 6.05 billion has total of 49,901K Shares Outstanding. Its annual sales at the moment are 385,690 K in contrast with the sum of -287,220 K annual income. Company’s last quarter sales were recorded 150,040 K and last quarter income was -47,970 K.
